PITTSBURGH, Feb. 27, 2025 /PRNewswire/ — Meets 2024 Guidance for Total Revenues, Adjusted […]
Tag: Viatris Inc.
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
PITTSBURGH, Sept. 17, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today the early tender results of the previously announced cash tender offer (the “Maximum Tender Offer”) of its subsidiary Utah […]
Viatris Announces Expiration and Results of Any and All Cash Tender Offers
PITTSBURGH, Sept. 10, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today that the previously announced cash tender offers (the “Any and All Tender Offers” and each, an “Any and All […]
Viatris Announces Cash Tender Offers for Certain Outstanding Notes
PITTSBURGH, Sept. 4, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today that it and its subsidiaries, Mylan Inc. (“Mylan”) and Utah Acquisition Sub Inc. (“Utah Acquisition” and, together with Viatris […]
Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress
Late-Breaking oral presentation shows that cenerimod for the treatment of moderate to severe systemic lupus erythematosus (SLE) in Japanese patients can be considered safe and well-tolerated Data shows a clinically meaningful improvement in disease activity consistent […]
